Literature DB >> 7760105

Blood flow and metabolic microenvironment of brain tumors.

P Vaupel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7760105     DOI： 10.1007/BF01052931

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  56 in total

1.  The effect of intra-arterial papaverine on the regional cerebral blood flow in patients with stroke or intracranial tumor.

Authors:  J Olesen; O B Paulson
Journal:  Stroke       Date:  1971 Mar-Apr       Impact factor: 7.914

2.  Relationship between of blood flow, glucose metabolism, protein synthesis, glucose and ATP content in experimentally-induced glioma (RG1 2.2) of rat brain.

Authors:  G Mies; W Paschen; G Ebhardt; K A Hossmann
Journal:  J Neurooncol       Date:  1990-08       Impact factor: 4.130

Review 3.  Positron emission tomography in the study of human tumors.

Authors:  R P Beaney
Journal:  Semin Nucl Med       Date:  1984-10       Impact factor: 4.446

4.  In vivo measurement of regional brain and tumor pH using [14C]dimethyloxazolidinedione and quantitative autoradiography. II: Characterization of the extracellular fluid compartment using pH-sensitive microelectrodes and [14C]sucrose.

Authors:  J B Arnold; R P Kraig; D A Rottenberg
Journal:  J Cereb Blood Flow Metab       Date:  1986-08       Impact factor: 6.200

5.  Concurrent measurements of blood flow and transcapillary transport in avian sarcoma virus-induced experimental brain tumors: implications for chemotherapy.

Authors:  R Blasberg; P Molnar; D Groothius; C Patlak; E Owens; J Fenstermacher
Journal:  J Pharmacol Exp Ther       Date:  1984-12       Impact factor: 4.030

6.  In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas.

Authors:  C G Rhodes; R J Wise; J M Gibbs; R S Frackowiak; J Hatazawa; A J Palmer; D G Thomas; T Jones
Journal:  Ann Neurol       Date:  1983-12       Impact factor: 10.422

7.  Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study.

Authors:  G Di Chiro; J Hatazawa; D A Katz; H V Rizzoli; D J De Michele
Journal:  Radiology       Date:  1987-08       Impact factor: 11.105

8.  In vivo MR spectroscopy of human subjects with a 1.4-T whole-body MR imager.

Authors:  T C Ng; A W Majors; T F Meany
Journal:  Radiology       Date:  1986-02       Impact factor: 11.105

9.  Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy.

Authors:  R D Oberhaensli; D Hilton-Jones; P J Bore; L J Hands; R P Rampling; G K Radda
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321

10.  In vivo nuclear magnetic resonance spectroscopy of a transplanted brain tumour.

Authors:  T H Koeze; P L Lantos; R A Iles; R E Gordon
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640
View more
  10 in total

1.  Response to commentary by Champ and Klement: Is a ketogenic diet the solution for the hyperglycemia problem in glioblastoma therapy?

Authors:  Arnulf Mayer; Peter Vaupel; Hans-Garlich Struss; Alf Giese; Marcus Stockinger; Heinz Schmidberger
Journal:  Strahlenther Onkol       Date:  2015-03       Impact factor: 3.621

Review 2.  Positron emission tomography in patients with primary CNS lymphomas.

Authors:  U Roelcke; K L Leenders
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

Review 3.  Antiangiogenic therapy in brain tumor models.

Authors:  H J Bernsen; A J van der Kogel
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

Review 4.  [Perfusion measurement using the T2* contrast media dynamics in neuro-oncology. Physical basics and clinical applications].

Authors:  M-A Weber; F Risse; F L Giesel; L R Schad; H-U Kauczor; M Essig
Journal:  Radiologe       Date:  2005-07       Impact factor: 0.635

5.  [Noninvasive measurement of relative cerebral blood flow with the blood bolus MRI arterial spin labeling: basic physics and clinical applications].

Authors:  M-A Weber; A Kroll; M Günther; S Delorme; J Debus; F L Giesel; M Essig; H-U Kauczor; L R Schad
Journal:  Radiologe       Date:  2004-02       Impact factor: 0.635

6.  Critical role of aberrant angiogenesis in the development of tumor hypoxia and associated radioresistance.

Authors:  Gabriele Multhoff; Jürgen Radons; Peter Vaupel
Journal:  Cancers (Basel)       Date:  2014-04-08       Impact factor: 6.639

7.  Kinomic profiling of glioblastoma cells reveals PLCG1 as a target in restricted glucose.

Authors:  Kiera Walker; Nathaniel H Boyd; Joshua C Anderson; Christopher D Willey; Anita B Hjelmeland
Journal:  Biomark Res       Date:  2018-06-14

Review 8.  Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.

Authors:  Hemant Sarin
Journal:  J Transl Med       Date:  2009-09-01       Impact factor: 5.531

Review 9.  Stress Response Leading to Resistance in Glioblastoma-The Need for Innovative Radiotherapy (iRT) Concepts.

Authors:  Stephanie E Combs; Thomas E Schmid; Peter Vaupel; Gabriele Multhoff
Journal:  Cancers (Basel)       Date:  2016-01-13       Impact factor: 6.639

Review 10.  How best to interpret measures of levels of oxygen in tissues to make them effective clinical tools for care of patients with cancer and other oxygen-dependent pathologies.

Authors:  Harold M Swartz; Ann Barry Flood; Philip E Schaner; Howard Halpern; Benjamin B Williams; Brian W Pogue; Bernard Gallez; Peter Vaupel
Journal:  Physiol Rep       Date:  2020-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.